The impact of female fetal sex on preeclampsia and the maternal immune milieu

The impact of female fetal sex on preeclampsia and the maternal immune milieu

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Brandie D. Taylor, Roberta B. Ness, Mark A. Klebanoff, Gong Tang, James M. Roberts, David M. Hougaard, Kristin Skogstrand, Catherine L. Haggerty
Hōputu:	Artigo
Reo:	Ingarihi
I whakaputaina:	2018
Urunga tuihono:	https://doi.org/10.1016/j.preghy.2018.02.009
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

The impact of female fetal sex on preeclampsia and the maternal immune milieu
mā: Taylor, Brandie D., me ētahi atu.
I whakaputaina: (2018)

Mid-pregnancy Circulating Immune Biomarkers in Women with Preeclampsia and Normotensive Controls
mā: Taylor, Brandie D., me ētahi atu.
I whakaputaina: (2015)

Mid-pregnancy circulating immune biomarkers in women with preeclampsia and normotensive controls
mā: Brandie D. Taylor, me ētahi atu.
I whakaputaina: (2015)

SERUM LEPTIN MEASURED IN EARLY PREGNANCY IS HIGHER IN WOMEN WITH PREECLAMPSIA COMPARED TO NORMOTENSIVE PREGNANT WOMEN
mā: Taylor, Brandie D., me ētahi atu.
I whakaputaina: (2014)

Serum Leptin Measured in Early Pregnancy Is Higher in Women With Preeclampsia Compared With Normotensive Pregnant Women
mā: Brandie D. Taylor, me ētahi atu.
I whakaputaina: (2014)

First and second trimester immune biomarkers in preeclamptic and normotensive women
mā: Taylor, Brandie D., me ētahi atu.
I whakaputaina: (2016)

First and second trimester immune biomarkers in preeclamptic and normotensive women
mā: Brandie D. Taylor, me ētahi atu.
I whakaputaina: (2016)

Prenatal Chlamydia trachomatis infection increases the risk of preeclampsia
mā: Haggerty, Catherine L., me ētahi atu.
I whakaputaina: (2013)

Maternal hormonal milieu influence on fetal brain development
mā: Miranda, Alexandra, me ētahi atu.
I whakaputaina: (2018)

Maternal hormonal milieu influence on fetal brain development
mā: Alexandra Miranda, me ētahi atu.
I whakaputaina: (2018)

Fetal Sex and Risk of Preeclampsia: Dose Maternal Race Matter?
mā: Mirzakhani, Hooman, me ētahi atu.
I whakaputaina: (2022)

Second trimester anti-angiogenic proteins and preeclampsia
mā: Haggerty, Catherine L., me ētahi atu.
I whakaputaina: (2012)

Microbial correlates of delayed care for pelvic inflammatory disease
mā: Taylor, Brandie D., me ētahi atu.
I whakaputaina: (2011)

Homocysteine, Cysteine, and Related Metabolites in Maternal and Fetal Plasma in Preeclampsia
mā: Kristin Brække, me ētahi atu.
I whakaputaina: (2007)

Periconceptional Multivitamin Use Reduces the Risk of Preeclampsia
mā: Lisa M. Bodnar, me ētahi atu.
I whakaputaina: (2006)

Placental polyamine metabolism differs by fetal sex, fetal growth restriction, and preeclampsia
mā: Sungsam Gong, me ētahi atu.
I whakaputaina: (2018)

Placental polyamine metabolism differs by fetal sex, fetal growth restriction, and preeclampsia
mā: Gong, Sungsam, me ētahi atu.
I whakaputaina: (2018)

Interactions between Smoking and Weight in Pregnancies Complicated by Preeclampsia and Small-for-Gestational-Age Birth
mā: Ness, Roberta B., me ētahi atu.
I whakaputaina: (2008)

The Impact of Preeclampsia on Gene Expression at the Maternal-Fetal Interface
mā: Winn, Virginia D., me ētahi atu.
I whakaputaina: (2011)

Is massive proteinuria associated with maternal and fetal morbidities in preeclampsia?
mā: Kim, Mi Jung, me ētahi atu.
I whakaputaina: (2017)

Quantitative Abnormalities of Fetal DNA in Maternal Serum in Preeclampsia
mā: Y. M. Dennis Lo, me ētahi atu.
I whakaputaina: (1999)

Exploring Inflammatory Mediators in Fetal and Maternal Compartments During Human Parturition
mā: Menon, Ramkumar, me ētahi atu.
I whakaputaina: (2019)

Exploring Inflammatory Mediators in Fetal and Maternal Compartments During Human Parturition
mā: Ramkumar Menon, me ētahi atu.
I whakaputaina: (2019)

Maternal Vitamin D Status and the Risk of Mild and Severe Preeclampsia
mā: Lisa M. Bodnar, me ētahi atu.
I whakaputaina: (2014)

Maternal vitamin D status and the risk of mild and severe preeclampsia
mā: Bodnar, Lisa M., me ētahi atu.
I whakaputaina: (2014)

Racial Variation in Toll-like Receptor Variants Among Women With Pelvic Inflammatory Disease
mā: Taylor, Brandie D., me ētahi atu.
I whakaputaina: (2013)

Fetal DNA Clearance from Maternal Plasma Is Impaired in Preeclampsia
mā: Tai-Wah Lau, me ētahi atu.
I whakaputaina: (2002)

Disturbed sex hormone milieu in males and females with major depressive disorder and low-grade inflammation
mā: Giulia Lombardo, me ētahi atu.
I whakaputaina: (2024)

Let’s Talk About Sex: Placentas’ Central Role in Sexually Dimorphic Responses to the Maternal Milieu
mā: O’Tierney-Ginn, Perrie
I whakaputaina: (2020)

The Role of Chlamydia trachomatis Polymorphic Membrane Proteins in Inflammation and Sequelae among Women with Pelvic Inflammatory Disease
mā: Taylor, Brandie D., me ētahi atu.
I whakaputaina: (2011)

Risk of Sequelae after<i>Chlamydia trachomatis</i>Genital Infection in Women
mā: Catherine L. Haggerty, me ētahi atu.
I whakaputaina: (2010)

Fetal-derived adrenomedullin mediates the innate immune milieu of the placenta
mā: Li, Manyu, me ētahi atu.
I whakaputaina: (2013)

Fetal-derived adrenomedullin mediates the innate immune milieu of the placenta
mā: Manyu Li, me ētahi atu.
I whakaputaina: (2013)

Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia
mā: Mittal, Pooja, me ētahi atu.
I whakaputaina: (2007)

Maternal Vitamin D and Fetal Growth in Early-Onset Severe Preeclampsia
mā: ROBINSON, Christopher J., me ētahi atu.
I whakaputaina: (2011)

Maternal and Fetal Alternative Complement Pathway Activation in Early Severe Preeclampsia
mā: Hoffman, M. Camille, me ētahi atu.
I whakaputaina: (2013)

The role of maternal serum catestatin in the evaluation of preeclampsia and fetal cardiac functions
mā: Özalp, Miraç, me ētahi atu.
I whakaputaina: (2021)

Maternal vitamin D and fetal growth in early-onset severe preeclampsia
mā: Christopher Robinson, me ētahi atu.
I whakaputaina: (2011)

Angiogenic and vasoactive proteins in the maternal-fetal interface in healthy pregnancies and preeclampsia
mā: Ane C. Westerberg, me ētahi atu.
I whakaputaina: (2024)

Maternal and Fetal Alternative Complement Pathway Activation in Early Severe Preeclampsia
mā: M. Camille Hoffman, me ētahi atu.
I whakaputaina: (2013)